Acs Research - Theorylab

Dr. Katy Rezvani of MD Anderson talks with the American Cancer Society about the: 1:30 – Biden Cancer Summit and Cancer Moonshot at MD Anderson. 2:55 – Urgency and excitement in immunotherapy 4:40 – On why she decided to go after natural killer cells instead of T cells 8:13 – Could there really be an off-the-shelf CAR NK cell? 9:12 – Three advantages of CAR NK cells 13:26 – Clinical trial she’s leading at MD Anderson 15:00 – Crucial early support from ACS